- Quantity
- 10 mg per vial
- CAS
- 218949-48-5
- Mol. weight
- 5135.9 g/mol
- Formula
- C221H366N72O67S
- Current lot
- TE-2609-08
Tesamorelin 10 mg Lyophilized GHRH Analogue Vial
- Quantity per vial10 mg
- FormLyophilized powder
- Purity≥99% by HPLC
- Molecular formulaC221H366N72O67S
$129.99
Tesamorelin, 10 mg lyophilized powder per vial, ≥99% by HPLC with identity by mass spectrometry. Lot-specific certificate of analysis available for download.
120 in stock
- Purity (HPLC)
- 99.7%
- Quantity
- 10 mg per vial
- Form
- Lyophilized powder in a sealed 3 mL glass vial
- Molecular formula
- C221H366N72O67S
- Molecular weight
- 5135.9 g/mol
- CAS number
- 218949-48-5
- Storage
- Lyophilized powder: store sealed at -20 °C, protected from light and moisture. Ships at ambient temperature with desiccant.
For laboratory research use only. Not for human or veterinary use, not for diagnostic or therapeutic use, not for human consumption. Sold to qualified researchers and institutions for in-vitro research. Handle in accordance with your institution's safety guidelines.
TE-2609-08- -20 °Cstore sealed, frozen
- Lightprotect from light
- Drydesiccant, keep dry
- 1Packed coldSealed vial, insulated mailer, desiccant
- 2Shipped trackedNext business day
- 3Straight to the freezerLog the lot against the certificate
Vial content and diluent volume → concentration, volume per draw and insulin-syringe units (U-100).
- Concentration
- —
- Volume per draw
- —
- Syringe units (U-100)
- —
- Draws per vial
- —
Laboratory preparation arithmetic (1 mL = 100 units on a U-100 syringe). No guidance on use. For laboratory research only; not for human or veterinary use.
Also known as: TH9507; trans-3-hexenoyl-GRF (1-44) All listings for CAS 218949-48-5 →
- Orders over $100−5%
SAVE5 - Orders over $200−10%
SAVE10
Tesamorelin is supplied as a lyophilized powder at 10 mg per vial. It is a synthetic 44-amino-acid GHRH analogue carrying an N-terminal trans-3-hexenoic acid group. Purity is ≥99% by HPLC, with identity confirmed by mass spectrometry, and a lot-specific certificate of analysis is available for download.
Specifications of the 10 mg Tesamorelin vial
- Compound
- Tesamorelin, synthetic 44-amino-acid GHRH analogue with N-terminal trans-3-hexenoic acid group
- Quantity per vial
- 10 mg
- Form
- Lyophilized powder
- Purity
- ≥99% by HPLC
- Identity confirmation
- Mass spectrometry
- Molecular formula
- C221H366N72O67S
- Molecular weight
- 5135.9 g/mol
- CAS number
- 218949-48-5
- Storage
- Sealed at -20 °C, protected from light and moisture
- Transit condition
- Ambient temperature with desiccant
- Shipped from
- Richmond, BC, insulated mailer with desiccant
- Packed dimensions
- 8×8×6 cm, shipping weight 0.05 kg
- Price
- $129.99 CAD
Why the 10 mg vial is documented per lot
Identity on record
Molecular formula C221H366N72O67S, molecular weight 5135.9 g/mol and CAS 218949-48-5 are stated for the material. A purchasing officer can match these figures against an internal specification before ordering.
Purity with its method
The figure is ≥99% by HPLC. Mass spectrometry confirms identity, so both the amount and the compound are addressed.
Certificate of analysis
Each lot ships with a downloadable certificate of analysis. The document is lot-specific, which keeps records traceable to the vial received.
Lyophilized form
The peptide arrives as a dry powder sealed in the vial. Powder is stored at -20 °C, protected from light and moisture.
Single unit
One vial contains 10 mg. No other fill size of this compound is listed, and no consumables are included with the vial.
Who the 10 mg Tesamorelin vial suits
The vial fits an in vitro laboratory that requires a GHRH analogue with a documented molecular weight of 5135.9 g/mol, and it fits a purchasing officer building a small order against a written specification that names CAS 218949-48-5. Because 10 mg is the only fill listed, a group needing a smaller working quantity of a different peptide should select another item in the catalogue. Ordering is limited to laboratories and qualified researchers, and the material is sold for research use only.
Storage is sealed at -20 °C, away from light and moisture. The certificate of analysis for the lot supplied is available for download and should be filed with the vial record. For laboratory research use only. Not for human or veterinary use.
Common questions
Does the vial come with a certificate of analysis?
Yes. A lot-specific certificate of analysis is available for download, stating ≥99% purity by HPLC with identity confirmed by mass spectrometry.
How should the lyophilized powder be stored on arrival?
Store the sealed vial at -20 °C, protected from light and moisture.
Where does the order ship from and in what packaging?
Orders ship from Richmond, BC in an insulated mailer with desiccant, at ambient temperature; the material is sold for research use only to laboratories and qualified researchers.
How it compares
Tesamorelin 10 mg Lyophilized GHRH Analogue Vial next to Bioglutide 10 mg Lyophilized Acylated Peptide Analogue Vial ($20.00 more) and Sermorelin (GHRH 1–29), 2 mg Lyophilized Vial ($85.00 less).
| Tesamorelin 10 mg Lyophilized GHRH Analogue Vial this page | Bioglutide 10 mg Lyophilized Acylated Peptide Analogue Vial | Sermorelin (GHRH 1–29), 2 mg Lyophilized Vial | |
|---|---|---|---|
| Price | $129.99 | $149.99 | $44.99 |
| Quantity | 10 mg per vial | 10 mg per vial | 2 mg per vial |
| Purity | 99.7% (HPLC) | 99.3% (HPLC) | 99.8% (HPLC) |
| Molecular weight | 5135.9 g/mol | — | 3357.9 g/mol |
| Formula | C221H366N72O67S | — | C149H246N44O42S |
| CAS | 218949-48-5 | — | 86168-78-7 |
| Form | Lyophilized powder in a sealed 3 mL glass vial | Lyophilized powder in a sealed 3 mL glass vial | Lyophilized powder in a sealed 3 mL glass vial |
Peer-reviewed literature
Journal articles indexed in PubMed for Tesamorelin. Provided as bibliographic reference only; they do not describe this product or any use of it.
- Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine PhysiciansPMID 41476424DOI 10.1177/03635465251357593
- TesamorelinPMID 31644039
- Advances in the detection of growth hormone releasing hormone synthetic analogsPMID 34665524DOI 10.1002/dta.3183
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future DirectionsPMID 41490200DOI 10.5435/JAAOSGlobal-D-25-00236
Read before you buy
Last updated September 23, 2026
